Sam Brusco, Associate Editor05.01.24
MMI (Medical Microinstruments Inc.) has completed the first U.S. clinical cases using its Symani surgical system. Both Both robotic-assisted microsurgical procedures were performed at the Department of Orthopaedic Surgery at Penn Presbyterian Medical Center.
The first U.S procedures were reconstructive extremity microsurgeries. One case was a “free bone transfer” on a patient who suffered a traumatic injury—a segment of bone and skin was transferred from the patient’s leg to a damaged forearm bone. The team revascularized the bone segment using the microsurgical robot to reconnect tiny blood vessels and facilitate successful transfer.
The second case was a patient risking leg amputation because of an infected knee prosthesis with soft tissue deficiency. The severe knee wound was repaired with muscle and skin from the patient’s back and the blood vessels were robotically reconnected to promote revascularization.
“The first U.S. cases are a paramount milestone in the global expansion of the Symani Surgical System, and we’re honored to have been able to work with Penn Medicine, a premiere orthopedic surgery department, to achieve it,” said Mark Toland, CEO at MMI. “Today marks the beginning of a new era in surgical innovation, as patients across the country with conditions that require complex microsurgical techniques, such as extremity reconstruction, autologous breast reconstruction post cancer resection and lymphedema repair, will now have expanded access to treatment options.”
The first U.S procedures were reconstructive extremity microsurgeries. One case was a “free bone transfer” on a patient who suffered a traumatic injury—a segment of bone and skin was transferred from the patient’s leg to a damaged forearm bone. The team revascularized the bone segment using the microsurgical robot to reconnect tiny blood vessels and facilitate successful transfer.
The second case was a patient risking leg amputation because of an infected knee prosthesis with soft tissue deficiency. The severe knee wound was repaired with muscle and skin from the patient’s back and the blood vessels were robotically reconnected to promote revascularization.
“The first U.S. cases are a paramount milestone in the global expansion of the Symani Surgical System, and we’re honored to have been able to work with Penn Medicine, a premiere orthopedic surgery department, to achieve it,” said Mark Toland, CEO at MMI. “Today marks the beginning of a new era in surgical innovation, as patients across the country with conditions that require complex microsurgical techniques, such as extremity reconstruction, autologous breast reconstruction post cancer resection and lymphedema repair, will now have expanded access to treatment options.”